Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
5.78
-0.26 (-4.30%)
At close: Mar 20, 2026, 4:00 PM EDT
5.77
-0.01 (-0.17%)
After-hours: Mar 20, 2026, 5:23 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $804.29 million as of March 20, 2026. Its market cap has increased by 175.05% in one year.
Market Cap
804.29M
Enterprise Value
816.37M
1-Year Change
175.05%
Ranking
Category
Stock Price
$5.78
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $804.29M, an increase of 432.65%. That is a compound annual growth rate of 25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.13B | 27.57% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 854.81M |
| Evommune | 840.31M |
| Sana Biotechnology | 829.96M |
| Adlai Nortye | 819.19M |
| Arbutus Biopharma | 815.45M |
| ARS Pharmaceuticals | 811.26M |
| Omeros | 779.91M |
| Cullinan Therapeutics | 771.10M |